B·R·A·H·M·S™ PlGF plus KRYPTOR™
Immunofluorescent assay for quantitative determination of Placental Growth Factor (PlGF)
Receive your quote directly from the manufacturer.
B·R·A·H·M·S provides a complete portfolio of biomarkers for the management of pre-eclampsia throughout the pregnancy.
B·R·A·H·M·S PlGF plus KRYPTOR is indicated as an aid for the early identification of women at risk of early onset pre-eclampsia in the first trimester, and with B·R·A·H·M·S sFlt-1 KRYPTOR, as aid for early prediction, diagnosis, and prognosis of pre-clampsia from week 20 and an identification of women at risk of developing term pre-eclampsia at week 36.
The B·R·A·H·M·S PlGF plus KRYPTOR test is also indicated as an aid to be used in conjunction with the clinical evaluation for non-invasive risk assessment of fetal trisomy 21 in first trimester in pregnant women.
Get confidence in your results with the high precision of B·R·A·H·M·S PlGF plus KRYPTOR and get results in less than 30 minutes.
